CPS Technologies Corp. filed its Form 10-Q for the fiscal quarter ended September 26, 2026, reporting third-quarter and nine-month financial results along with a significant common stock issuance completed during the period.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing a 6% beneficial ownership position in Universal Corp/VA as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 3,010,531 shares of Vanda Pharmaceuticals Inc. common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 14,433,295 shares of common stock in USA Rare Earth Inc as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 3,301,893 shares of Vera Therapeutics Inc common stock as of September 30, 2026.
Exagen Inc. filed a Form S-3 registration statement with the SEC on November 10, 2026, covering up to $150.0 million in securities and including a sales agreement prospectus supplement for up to $50.0 million in common stock through TD Securities (USA) LLC.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 4,020,999 shares of Verastem Inc common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 7,822,781 shares of Vir Biotechnology Inc common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing a 6% beneficial ownership position in Voyager Technologies Inc. common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 2,001,159 shares of Wolfspeed Inc common stock as of September 30, 2026.